KRISTALLINE FORMEN EINES SGC-STIMULATORS

European patent · EP3762389 · In force

Register entry

Publication number
EP3762389
Application number
EP19712427
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 7, 2019
Published
Jan 13, 2021
Granted
Feb 28, 2024
Protection ends at the latest
Mar 6, 2039
Next annual fee due
Mar 31, 2027
IPC classes
C07D 487/04 (2006.01)
A61K 31/4985 (2006.01)
A61P 25/00 (2006.01)
Priority
US 201862639846 P 07.03.2018
PCT application
PCT/US2019/021080 07.03.2019
PCT publication
WO2019/173551 12.09.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Jan 8, 2025

    Change

    Published in Swissreg on 08.01.2025

  4. May 27, 2024

    Agent entered

    Representative
    MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex

    Published in Swissreg on 27.05.2024

  5. Apr 29, 2024

    Change

    Published in Swissreg on 29.04.2024

  6. Feb 28, 2024

    Granted

    Published in Swissreg on 28.02.2024

Parties

Holder

Tisento Therapeutics Inc.

245 First Street Riverview II, 18th Floor, Cambridge, MA 02142, US

Agent

MICHELI & CIE SA

122, rue de Genève, CP 61, 1226 Thônex

Inventor

STORZ, Thomas

Cambridge, MA 02142, US

PRASAD, Leena, Kumari

Cambridge, MA 02142, US

NTI-ADDAE, Kwame, W.

Cambridge, MA 02142, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.